All Chemistry World articles in Archive 2004-2009 – Page 126
-
Opinion
Editorial: Chemistry and climate change
The UK government has long seen itself as a world leader in tackling climate change
-
Business
Business roundup: April 2007
Pharma’s house of cards Anglo-Swedish drug company AstraZeneca has announced plans to cut roughly 700 jobs at its site in Macclesfield, UK. A further 850 staff will go at Swedish production facilities. The news marks the first step in the implementation of the company’s plans to cut 3000 jobs from ...
-
News
Harmonising pharmaceutical quality worldwide
All change at the European Pharmacopoeia, the Strasbourg-based organisation responsible for European pharmaceutical quality standards
-
News
Termites' enzyme anomaly
Termites rely on symbiotic bacteria to digest cellulose, so why do they digest some cellulose themselves?
-
News
World's smallest bowl of 'alphabet soup'
A suspension of microscopic letters marks a key step towards complex engineering on the nanoscale.
-
NewsPollens reveal origins of terracotta army
Scientists put ancient clay figures under the microscope
-
News
Eat isotopes to live longer
Deuterium and carbon-13 could be used to suppress the ageing reactions attributed to reactive oxygen species
-
News
The metamaterials space race
Technology making invisibility shields a theoretical possibility has taken a major step forward
-
News
Cold fusion back on the menu
PREVIEW: American Chemical Society meeting sees return of an old controversy.
-
News
The molecular cannibal in vitamin B12 synthesis
Scientists have put in place the final piece of a puzzle started 20 years ago.
-
News
Forcing a reaction
US chemists have forced molecules to react by ripping their bonds apart with ultrasound.
-
News
Synthesis strategy offers no protection
Streamlined method of constructing complex molecules could help tap nature's bounty.
-
News
Is your lab ready to go veggie?
Vegetable reagents mean chemists in developing countries could save a bunch
-
News
Testing times for 'mega-pharma'
Industry experts address what can be done to stop big pharma from engineering its own demise.